An Antibody against the C-Terminal Domain of PCSK9 Lowers LDL Cholesterol Levels In Vivo
Felix Schiele(Boehringer Ingelheim (Germany)), Herbert Nar(Boehringer Ingelheim (Germany)), Gerd Luippold(Boehringer Ingelheim (Germany)), Norbert Redemann(Boehringer Ingelheim (Germany)), John Park(Boehringer Ingelheim (Germany))
Cited by 35
Related Papers
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
The Dissociation of Cohesin from Chromosomes in Prophase Is Regulated by Polo-like Kinase
|Molecular Cell|2002|449
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383